Maintenance of response following discontinuation of guselkumab and secukinumab in Spanish patients who participated in the ECLIPSE study.
Raquel Rivera-DíazAntonio MartorellA LópezL SalgadoAntonio Sahuquillo-TorralbaP de la CuevaP HerranzJ A RatónM FerránR IzuDiana P Ruiz GenaoC García-DonosoJ M CarrascosaPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)